By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Incyte Corporation 

Experimental Station
Route 141 & Henry Clay Road, Building E336
Wilmington  Delaware  19880  U.S.A.
Phone: 302-498-6700 Fax: 302-425-2750


Company News
Incyte (INCY) Reports 2015 First-Quarter Financial Results And Updates Shareholders On Key Clinical Programs 4/30/2015 12:32:40 PM
Incyte (INCY) To Present At Upcoming Investor Conferences 4/23/2015 10:21:37 AM
Incyte (INCY)’s Emerging Development Pipeline Described In Eleven Abstracts At 2015 American Association for Cancer Research Annual Meeting 4/17/2015 7:56:01 AM
Incyte (INCY) To Report First Quarter Financial Results On April 30 4/14/2015 11:31:32 AM
Incyte (INCY) Targets Switzerland for a New Clinical Development HQ 4/14/2015 5:57:22 AM
Incyte Corporation (INCY) Release: Jakavi (ruxolitinib) Receives European Commission Approval As First Targeted Therapy For Patients With Polycythemia Vera 3/17/2015 11:16:25 AM
Incyte Corporation (INCY) Appoints Steven H. Stein, MD As Chief Medical Officer 3/2/2015 10:34:36 AM
Incyte Corporation (INCY) Sponsors First Observational Study Designed To Understand The Impact Of Polycythemia Vera—A Rare, Progressive Blood Cancer 2/26/2015 9:42:57 AM
Incyte Corporation (INCY) To Present At Upcoming Investor Conferences 2/17/2015 12:28:26 PM
Incyte Corporation (INCY) Reports 2014 Fourth-Quarter And Year-End Financial Results; Provides 2015 Financial Guidance; Updates Shareholders On Key Clinical Programs 2/12/2015 7:55:59 AM